$维视图像(MVIS.US)$ shareholders might be concerned after seeing the share price drop 15% in the last quarter. But over three years the performance has been really wonderful. Indeed, the share price is up a whopping 322% in that time. Arguably, the recent fall is to be expected after such a strong rise. The only way to form a view of whether the current price is justified is to consider the merits of the business itself.
Since the stock has added US$69m to its market cap in the past week alone, let's see if underlying performance has been driving long-term returns.
Check out our latest analysis for MicroVision
MicroVision wasn't profitable in the last twelve months, it is unlikely we'll see a strong correlation between its share price and its earnings per share (EPS). Arguably revenue is our next best option. Shareholders of unprofitable companies usually expect strong revenue growth. As you can imagine, fast revenue growth, when maintained, often leads to fast profit growth.
MicroVision actually saw its revenue drop by 70% per year over three years. This is in stark contrast to the strong share price growth of 62%, compound, per year. There can be no doubt this kind of decoupling of revenue growth and share price growth is unusual to see in loss making companies. So there is a serious possibility that some holders are counting their chickens before they hatch.
If you are thinking of buying or selling MicroVision stock, you should check out this FREE detailed report on its balance sheet.
A Different Perspective
While the broader market lost about 10% in the twelve months, MicroVision shareholders did even worse, losing 78%. However, it could simply be that the share price has been impacted by broader market jitters. It might be worth keeping an eye on the fundamentals, in case there's a good opportunity. Longer term investors wouldn't be so upset, since they would have made 8%, each year, over five years. If the fundamental data continues to indicate long term sustainable growth, the current sell-off could be an opportunity worth considering. It's always interesting to track share price performance over the longer term. But to understand MicroVision better, we need to consider many other factors. For example, we've discovered 3 warning signs for MicroVision that you should be aware of before investing here.
If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of companies that have proven they can grow earnings.
Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on US exchanges.
We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has
$维视图像(MVIS.US)$股东在看到上个季度股价下跌15%后可能会感到担忧。但在三年多的时间里,表演真的很精彩。事实上,在这段时间里,该公司股价大幅上涨了322%。可以说,在如此强劲的上涨之后,最近的下跌是意料之中的。要判断当前价格是否合理,唯一的办法是考虑企业本身的优点。
由于该股仅在过去一周就增加了6900万美元的市值,让我们看看潜在表现是否一直在推动长期回报。
查看我们对MicroVision的最新分析
Microvision在过去的12个月里没有盈利,我们不太可能看到它的股价和每股收益(EPS)之间有很强的相关性。可以说,收入是我们的下一个最佳选择。未盈利公司的股东通常预期营收增长强劲。正如你可以想象的那样,快速的收入增长,如果保持下去,往往会带来快速的利润增长。
事实上,Microvision的收入在三年内以每年70%的速度下降。这与股价每年62%的强劲复合增长形成了鲜明对比。毫无疑问,这种收入增长和股价增长脱钩的情况在亏损公司中是不常见的。因此,很有可能一些养鸡者在鸡孵化前就开始数鸡了。
不同的视角
虽然大盘在过去12个月中下跌了约10%,但MicroVision的股东表现更差,跌幅为78%。然而,这可能只是因为股价受到了更广泛的市场紧张情绪的影响。也许有必要关注基本面,以防出现良机。较长期的投资者不会如此沮丧,因为他们在五年内每年会获得8%的收益。如果基本面数据继续显示长期可持续增长,当前的抛售可能是一个值得考虑的机会。跟踪股价的长期表现总是很有趣的。但为了更好地理解MicroVision,我们需要考虑许多其他因素。例如,我们发现MicroVision的3个警告标志,在这里投资之前你应该意识到这一点。
如果你更愿意看看另一家公司--一家财务状况可能更好的公司--那么不要错过这一点免费已证明自己能够实现盈利增长的公司名单。
请注意,本文引用的市场回报反映了目前在美国交易所交易的股票的市场加权平均回报。
我们仅使用不偏不倚的方法提供基于历史数据和分析师预测的评论,我们的文章并不打算作为财务建议。它不构成买卖任何股票的建议,也没有考虑你的目标或你的财务状况。我们的目标是为您带来由基本面数据驱动的长期重点分析。请注意,我们的分析可能不会将最新的对价格敏感的公司公告或定性材料考虑在内。